Literature DB >> 14871524

CA-125 levels in predicting optimal cytoreductive surgery in patients with advanced epithelial ovarian carcinoma.

J L Alcázar1, D Miranda, A Unanue, E Novoa, S Alemán, L Madariaga.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14871524     DOI： 10.1016/j.ijgo.2003.10.006

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN： 0020-7292            Impact factor:   3.561


× No keyword cloud information.
  3 in total

Review 1.  Prognostic and predictive value of CA-125 in the primary treatment of epithelial ovarian cancer: potentials and pitfalls.

Authors:  Iván Díaz-Padilla; Albiruni Ryan Abdul Razak; Lucas Minig; Marcus Q Bernardini; Josep María Del Campo
Journal:  Clin Transl Oncol       Date:  2012-01       Impact factor: 3.405

Review 2.  A framework for a personalized surgical approach to ovarian cancer.

Authors:  Alpa M Nick; Robert L Coleman; Pedro T Ramirez; Anil K Sood
Journal:  Nat Rev Clin Oncol       Date:  2015-02-24       Impact factor: 66.675

Review 3.  The Significance of Normal Pretreatment Levels of CA125 (<35 U/mL) in Epithelial Ovarian Carcinoma.

Authors:  Joseph Menczer; Erez Ben-Shem; Abraham Golan; Tally Levy
Journal:  Rambam Maimonides Med J       Date:  2015-01-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.